IRVING, Texas, Aug. 12, 2025 /PRNewswire/ -- Caris Life Sciences, Inc. (Nasdaq: CAI), a leading, patient-centric, next-generation AI TechBio company, today reported financial results...
New Identity and Cybersecurity Concerns (ICC) Perspectives Series to be published in a series of data reports to equip organizations with deeper demographic insights
WASHINGTON,...
Seasoned sales leader with proven track record of scaling cybersecurity companies to lead worldwide go-to-market strategy
NEW YORK, Aug. 12, 2025 /PRNewswire/ -- OX, a leader...
Health-ISAC warns of rising cyber threats to Brazil’s healthcare sector, urging better intelligence sharing to protect patient data and infrastructure.
MarketNewsUpdates News Commentary
NEW YORK, Aug. 11, 2025 /CNW/ -- Industry insiders say that the global demand for Antimony market is expected to continue growing...
MarketNewsUpdates News Commentary
NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Industry insiders say that the global demand for Antimony market is expected to continue growing...
MarketNewsUpdates News Commentary
NEW YORK, Aug. 11, 2025 /PRNewswire/ -- Industry insiders say that the global demand for Antimony market is expected to continue growing...
HONG KONG, Aug. 11, 2025 /PRNewswire/ -- Tencent Cloud, the cloud business of global technology company Tencent, today announced the upgrade of its AIoT 2.0...
ROAD TOWN, British Virgin Islands, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Ozak AI’s growth is showing no signs of slowing down, with the project now surpassing $1.6 million in total funds raised. Over 90 million $OZ tokens have already been sold out, demonstrating the surging demand from crypto investors keen to gain exposure to one of the most talked-about AI-driven crypto initiatives this year.
AutoSave is now live in Ohio, Illinois, and Washington, D.C., with additional markets coming soon.
NEW YORK, Aug. 8, 2025 /PRNewswire/ -- Think+ Network ("Think+"),...
August 8, 2025: Update
OTTAWA, ON, Aug. 8, 2025 /CNW/ -
This outbreak investigation is ongoing. The public health notice will be updated as the investigation...
TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today reported financial results for the three and nine months ended June 30, 2025 and provided an update on its business.